Skip to content

Clinical trials

Obesity trials in India

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Obesity Country / region: India Clear all

72 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20063
20081
20103
20114
20124
20141
20162
20172
20183
20192
20202
20214
20226
202310
20244
20254
202615

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed37
Recruiting14
Unknown status8
Active, not recruiting6
Not yet recruiting4
Terminated2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S20
Eli Lilly and Company16
Diabetes Foundation, India3
Asian Institute of Gastroenterology, India2
AstraZeneca2
Neurovalens Ltd.2
Post Graduate Institute of Medical Education and Research, Chandigarh2
Zydus Lifesciences Limited2
All India Institute of Medical Sciences, Bhubaneswar1
Asian Institute of Public Health1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Obesity72
Overweight32
Diabetes Mellitus, Type 214
Diabetes Mellitus5
Metabolic Syndrome5
Nutrition Disorders5
Sleep Apnea, Obstructive5
Insulin Resistance4
Dyslipidemias3
Hypertension3

Trials

Showing 51 to 72 of 72. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.